BODY COMPOSITION CHANGES ARE NOT ASSOCIATED WITH INFLAMMATORY AND METABOLIC MARKERS IN PATIENTS WITH ADVANCED PROSTATE CANCER MANAGED WITH ANDROGEN DEPRIVATION THERAPY

Journal Title: European Journal of Biomedical and Pharmaceutical Sciences - Year 2019, Vol 6, Issue 8

Abstract

Background: The primary treatment of advanced prostate cancer is based on pharmacological or surgical androgen-deprivation therapy (ADT). Inhibition of testosterone production that interrupts testosterone-induced growth of the prostate tumor has several undesirable effects on the metabolic profile. However, these effects are not completely understood. The purpose of this study was to evaluate the changes in body composition and inflammatory / metabolic profile in men managed with ADT for advanced prostate cancer. Methods: In this prospective study, 17 patients (77.56.74 years) with advanced prostate cancer underwent pharmacological or surgical ADT. Clinical, body composition, inflammatory and metabolic parameters were determined before and after 6 months of surgery. Results: All patients presented significant decreases in testosterone (p=0.001) and PSA (p<0.001) levels after ADT. Body composition parameters increased markedly: weight (71.512.8 to 74.713.5 kg, p<0.001), body mass index (25.73.3 to 26.93.3 kg/m2, p<0.001) and waist circumference (96.511.3 to 99.510.1 cm, p=0.004). Marked changes were noted on blood levels of insulin (9.43.1 to 12.64.1 mU/L, p<0.001) and leptin (6022.05928.4 to 9612.16279.0 pg/mL, p=0.017). However, inflammatory (fibrinogen, Creactive protein, interleukin-6, tumor necrosis factor alpha, monocyte chemoattractant protein-1, intercellular adhesion molecule-1, vascular adhesion molecule-1 and adiponectin) and metabolic (glycemic and lipid profiles) markers did not present significant variations. Conclusions: These data demonstrate that, among men with advanced prostate cancer treated by ADT, the marked changes in body composition after 6 months did not reflect changes in inflammatory and metabolic markers. Thus, an association between ADT and inflammatory / metabolic markers is yet to be described.

Authors and Affiliations

Dr. Carlos V. Serrano

Keywords

Related Articles

ENVIRONMENT AND HEALTH

Several factors affect the environment such as topographic or physiographic factors, climatic factors, edaphic factors and biotic factors. Life of organisms is affected by the combination of all these ecological factors....

HISTOLOGICAL STUDIES OF LARVAL DEVELOPMENT STAGES IN DIGESTIVE ANNEX GLANDS

Bibliography and background: Concerning to the histological structures of accessory digestive glands in A.stellatus larvae few data is available. Implication and statement of the importance: Reading to the importance of...

A STUDY ON BMI AND SKINFOLD THICKNESSES AS PREDICTORS OF BLOOD PRESSURE LEVEL IN ADOLESCENTS

Hypertension is a global health challenge. Hence, the need for better understanding to promote awareness on its early detection and treatment is now emphasized in preventive medicine. This study examined the relationship...

SHORT STATURE IDENTIFIED IN CHILDREN PRESENTING AT MAKASSED GENERAL HOSPITAL

Background: Longitudinal growth assessment is essential in children at an early period. Short stature can be promptly recognized only with accurate measurements of growth, critical analysis of growth data as well as thor...

THE INVESTIGATION OF PHYSIOLOGICAL KNOWLEDGE AND FIRST AID APPLIED TO THE CURRICULAR GRID OF PREHOSPITAL CARE IN PHYSICAL EDUCATION COURSES IN BELÉM-PA, BRAZIL, EASTERN AMAZON

The present study aims to analyze the degree of knowledge about physiology and first aid applied to the prehospital care of the graduating students of the physical education course of the main colleges of the metropolita...

Download PDF file
  • EP ID EP671118
  • DOI -
  • Views 162
  • Downloads 0

How To Cite

Dr. Carlos V. Serrano (2019). BODY COMPOSITION CHANGES ARE NOT ASSOCIATED WITH INFLAMMATORY AND METABOLIC MARKERS IN PATIENTS WITH ADVANCED PROSTATE CANCER MANAGED WITH ANDROGEN DEPRIVATION THERAPY. European Journal of Biomedical and Pharmaceutical Sciences, 6(8), 53-61. https://europub.co.uk./articles/-A-671118